Τομέας Κλινικοεργαστηριακός

25. Accumulation of dietary glycotoxins in the reproductive system of normal female rats. Diamanti-Kandarakis E, Piperi C,
Korkolopoulou P, Kandaraki E, Levidou G, Papalois A, Patsouris E, Papavassiliou AG J Mol Med. 2007 Dec; 85(12):1413-
20.
26. Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of
patients with astroglial tumors. Samaras V, Piperi C, Korkolopoulou P, Zisakis A, Levidou G, Themistocleous MS, Boviatsis
EI, Sakas DE, Lea RW, Kalofoutis A, Patsouris E Mol Cell Biochem. 2007 Oct; 304(1-2):343-51.
27. Vitamin B12 and hepatic enzyme serum levels correlate with interleukin-6 in alcohol-dependent individuals without liver
diseasE Liappas IA, Nicolaou C, Chatzipanagiotou S, Tzavellas EO, Piperi C, Papageorgiou C, Boufidou F, Bagos P, Soldatos
CR. Clin Biochem. 2007 Jul; 40(11):781-6.
28. Correlation of folate, vitamin B12 and homocysteine plasma levels with depression in an elderly Greek population. Dimopoulos
N, Piperi C, Salonicioti A, Psarra V, Gazi F, Papadimitriou A, Lea RW, Kalofoutis A. Clin Biochem. 2007 Jun; 40(9-
10):604-8.
29. Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Matzaraki V, Alexandraki KI, Venetsanou
K, Piperi C, Myrianthefs P, Malamos N, Giannakakis T, Karatzas S, Diamanti-Kandarakis E, Baltopoulos G Clin
Biochem. 2007 Mar; 40(5-6):336-42.
30. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and
normal ovaries. Diamanti-Kandarakis E, Piperi C, Patsouris E, Korkolopoulou P, Panidis D, Pawelczyk L, Papavassiliou AG,
Duleba AJ. Histochem Cell Biol. 2007 Jun; 127(6):581-9.
31. Association of cognitive impairment with plasma levels of folate, vitamin B12 and homocysteine in the elderly. Dimopoulos
N, Piperi C, Salonicioti A, Psarra V, Gazi F, Nounopoulos C, Lea RW, Kalofoutis A. In Vivo. 2006 Nov-Dec;
20(6B):895-9.
32. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary
syndromE Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D. Clin Endocrinol (Oxf). 2007 Jan;
66(1):103-9.
33. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndromE
Diamanti-Kandarakis E, Alexandraki K, Piperi C, Aessopos A, Paterakis T, Katsikis I, Panidis D. Metabolism. 2007
Jan; 56(1):129-34.
34. Differences in expression of cardiovascular risk factors among type 2 diabetes mellitus patients of different agE Kalofoutis
C, Piperi C, Zisaki A, Singh J, Harris F, Phoenix D, Alaveras A, Kalofoutis A. Ann N Y Acad Sci. 2006 Nov; 1084:166-77.
35. Inflammatory process in type 2 diabetes: The role of cytokines. Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A,
Kalofoutis A. Ann N Y Acad Sci. 2006 Nov; 1084:89-117. Review.
36. Effect of alcohol detoxification on serum S-100B levels of alcohol-dependent individuals. Liappas I, Tzavellas EO, Kariyannis
C, Piperi C, Schulpis C, Papassotiriou I, Soldatos CR. In Vivo. 2006 Sep-Oct; 20(5):675-80.
37. Inflammatory and endothelial markers in women with polycystic ovary syndromE Diamanti-Kandarakis E, Alexandraki K,
Piperi C, Protogerou A, Katsikis I, Paterakis T, Lekakis J, Panidis D. Eur J Clin Invest. 2006 Oct; 36(10):691-7.
38. Elevation of plasma concentration of adhesion molecules in late-life depression. Dimopoulos N, Piperi C, Salonicioti A,
Mitsonis C, Liappas I, Lea RW, Kalofoutis A. Int J Geriatr Psychiatry. 2006 Oct; 21(10):965-71.
39. Interleukin-1 alpha and beta, TNF-alpha and HTTLPR gene variants study on alcohol toxicity and detoxification outcomE
Serretti A, Liappas I, Mandelli L, Albani D, Forloni G, Malitas P, Piperi C, Zisaki A, Tzavellas EO, Papadopoulou-Daifoti Z,
Prato F, Batelli S, Pesaresi M, Kalofoutis A. Neurosci Lett. 2006 Oct 2; 406(1-2):107-12.
40. Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression
and survival. Perdiki M, Korkolopoulou P, Thymara I, Agrogiannis G, Piperi C, Boviatsis E, Kotsiakis X, Angelidakis D, Diamantopoulou
K, Thomas-Tsagli E, Patsouris E Mol Cell Biochem. 2007 Jan; 295(1-2):75-83.
41. Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndromE
Alexandraki K, Protogerou AD, Papaioannou TG, Piperi C, Mastorakos G, Lekakis J, Panidis D, Diamanti-Kandarakis
E Hormones (Athens). 2006 Apr-Jun; 5(2):126-36.
42. Polycystic ovary syndrome: the influence of environmental and genetic factors. Diamanti-Kandarakis E, Piperi C, Spina J,
Argyrakopoulou G, Papanastasiou L, Bergiele A, Panidis D. Hormones (Athens). 2006 Jan-Mar; 5(1):17-34. Review.
43. Interrelationship of hepatic function, thyroid activity and mood status in alcohol-dependent individuals. Liappas I, Piperi C,
Malitas PN, Tzavellas EO, Zisaki A, Liappas AI, Kalofoutis CA, Boufidou F, Bagos P, Rabavilas A, Kalofoutis A. In Vivo. 2006
Mar-Apr; 20(2):293-300.
44. Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndromE Diamanti-Kandarakis
E, Piperi C, Alexandraki K, Katsilambros N, Kouroupi E, Papailiou J, Lazaridis S, Koulouri E, Kandarakis HA,
Douzinas EE, Creatsas G, Kalofoutis A. Metabolism. 2006 Apr; 55(4):494-500.
45. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Diamanti-
Kandarakis E, Paterakis T, Alexandraki K, Piperi C, Aessopos A, Katsikis I, Katsilambros N, Kreatsas G, Panidis D. Hum Reprod.
2006 Jun; 21(6):1426-31.
2112 ¸êèåóç ÅóùôåñéêÞò Áîéïëüãçóçò (Ðñüôõðï ó÷Þìá)